These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2566315)

  • 1. Maladaptive behaviors associated with neuroleptic drug maintenance.
    Chadsey-Rusch J; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):607-17. PubMed ID: 2566315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective study of lithium use for institutionalized mentally retarded individuals with behavior disorders.
    Langee HR
    Am J Ment Retard; 1990 Jan; 94(4):448-52. PubMed ID: 2105098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neuroleptic drugs on the intellectual and habilitative behaviors of mentally retarded persons.
    Ferguson DG
    Psychopharmacol Bull; 1982 Jan; 18(1):54-6. PubMed ID: 6152871
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication and programming in controlling the behavior of mentally retarded individuals in community settings.
    Schalock RL; Foley JW; Toulouse A; Stark JA
    Am J Ment Defic; 1985 Mar; 89(5):503-9. PubMed ID: 2859807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies for self-injurious behavior in a large service-delivery network.
    Altmeyer BK; Locke BJ; Griffin JC; Ricketts RW; Williams DE; Mason M; Stark MT
    Am J Ment Defic; 1987 Jan; 91(4):333-40. PubMed ID: 3812603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic management of aggressivity and self-mutilation in the mentally retarded.
    Lapierre YD; Reesal R
    Psychiatr Clin North Am; 1986 Dec; 9(4):745-54. PubMed ID: 3543893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of self-injurious behavior and other maladaptive behaviors among individuals with severe and profound intellectual disability.
    Matson JL; Cooper C; Malone CJ; Moskow SL
    Res Dev Disabil; 2008; 29(2):141-8. PubMed ID: 17350800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interdisciplinary team review on the use of antipsychotic agents with severely and profoundly mentally retarded persons.
    Glaser BA; Morreau LE
    Am J Ment Defic; 1986 Jan; 90(4):371-9. PubMed ID: 3946474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons.
    Ratey JJ; Sovner R; Mikkelsen E; Chmielinski HE
    J Clin Psychiatry; 1989 Oct; 50(10):382-4. PubMed ID: 2793836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of methylperon (Eunerpan) on aggressive and auto-aggressive behaviour in mentally retarded patients--a double blind study (author's transl)].
    Hacke W; Büssing A; Jungen K
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):86-96. PubMed ID: 25446
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychopharmacology of self-injurious behavior in the mentally retarded.
    Farber JM
    J Am Acad Child Adolesc Psychiatry; 1987 May; 26(3):296-302. PubMed ID: 2885304
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of the dexamethasone suppression test to detect depressive disorders of mentally retarded individuals.
    Pirodsky DM; Gibbs JW; Hesse RA; Hsieh MC; Krause RB; Rodriguez WH
    Am J Ment Defic; 1985 Nov; 90(3):245-52. PubMed ID: 4083305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose haloperidol for stereotypic self-injurious behavior in the mentally retarded.
    Mikkelsen EJ
    N Engl J Med; 1986 Aug; 315(6):398-9. PubMed ID: 3736616
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and prediction of psychotropic drug use in California developmental centers.
    Stone RK; Alvarez WF; Ellman G; Hom AC; White JF
    Am J Ment Retard; 1989 May; 93(6):627-32. PubMed ID: 2719845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta adrenergic blocking medications for aggressive or self-injurious mentally retarded persons.
    Ruedrich SL; Grush L; Wilson J
    Am J Ment Retard; 1990 Jul; 95(1):110-9. PubMed ID: 1974768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analytic study on treatment effectiveness for problem behaviors with individuals who have mental retardation.
    Didden R; Duker PC; Korzilius H
    Am J Ment Retard; 1997 Jan; 101(4):387-99. PubMed ID: 9017085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded.
    Luchins DJ; Dojka D
    Psychopharmacol Bull; 1989; 25(3):372-5. PubMed ID: 2626515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of sedative-hypnotic response to self-injurious behavior and stereotypy by mentally retarded clients.
    Barron J; Sandman CA
    Am J Ment Defic; 1983 Sep; 88(2):177-86. PubMed ID: 6638079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basing the treatment of stereotypic and self-injurious behaviors on hypotheses of their causes.
    Repp AC; Felce D; Barton LE
    J Appl Behav Anal; 1988; 21(3):281-9. PubMed ID: 3198549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.